Patents Assigned to Apeximmune Therapeutics Inc.
  • METHODS AND COMPOSITIONS FOR TREATING CANCER OR VIRAL INFECTION WITH A PLA2G2D ANTAGONIST
    Publication number: 20230075779
    Abstract: The present application provides methods of treating a disease (such as cancer or infectious disease) that involves an antagonist that targets PLA2G2D signaling pathway (such as an antagonist that targets PLA2G2D. The present application also provides non-naturally occurring PLA2G2D polypeptides.
    Type: Application
    Filed: January 29, 2021
    Publication date: March 9, 2023
    Applicant: Apeximmune Therapeutics Inc.
    Inventors: Li-Fen LEE, Kan LU, Jessica YU, Sheng-Tien LI, Julie HUANG, Katharine YU